BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26818394)

  • 21. Natural Age-Related Slow-Wave Sleep Alterations Onset Prematurely in the Tg2576 Mouse Model of Alzheimer's Disease.
    Kollarik S; Dias I; Moreira CG; Bimbiryte D; Miladinovic D; Buhmann JM; Baumann CR; Noain D
    Neurodegener Dis; 2022; 22(2):55-67. PubMed ID: 36302349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The early changes in behavior and the myelinated fibers of the white matter in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Zhang L; Lu W; Chen L; Qiu X; Li C; Huang CX; Gong X; Min QC; Lu F; Wan JY; Chao FL; Tang Y
    Neurosci Lett; 2013 Oct; 555():112-7. PubMed ID: 24060675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe motor neuron degeneration in the spinal cord of the Tg2576 mouse model of Alzheimer disease.
    Seo JS; Leem YH; Lee KW; Kim SW; Lee JK; Han PL
    J Alzheimers Dis; 2010; 21(1):263-76. PubMed ID: 20421695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
    J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-Amyloid pathology alters neural network activation during retrieval of contextual fear memories in a mouse model of Alzheimer's disease.
    Lelos MJ; Good MA
    Eur J Neurosci; 2014 May; 39(10):1690-703. PubMed ID: 24628842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of electroacupuncture on the behavior and the expression of amyloid beta-protein, amyloid precursor protein and ChAT in APP 695 V 717 I transgenic mice].
    Xue WG; Zhang Z; Bai LM; Xu H; Wu HX
    Zhen Ci Yan Jiu; 2009 Jun; 34(3):152-8. PubMed ID: 19761106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Object recognition memory and cholinergic parameters in mice expressing human presenilin 1 transgenes.
    Vaucher E; Fluit P; Chishti MA; Westaway D; Mount HT; Kar S
    Exp Neurol; 2002 Jun; 175(2):398-406. PubMed ID: 12061869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
    Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
    J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease.
    Zilberter M; Ivanov A; Ziyatdinova S; Mukhtarov M; Malkov A; Alpár A; Tortoriello G; Botting CH; Fülöp L; Osypov AA; Pitkänen A; Tanila H; Harkany T; Zilberter Y
    J Neurochem; 2013 Apr; 125(1):157-71. PubMed ID: 23241062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
    Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice.
    Gerenu G; Dobarro M; Ramirez MJ; Gil-Bea FJ
    Biochim Biophys Acta; 2013 Jun; 1832(6):837-47. PubMed ID: 23474306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse.
    Jyoti A; Plano A; Riedel G; Platt B
    J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease.
    Grand'maison M; Zehntner SP; Ho MK; Hébert F; Wood A; Carbonell F; Zijdenbos AP; Hamel E; Bedell BJ
    Neurobiol Dis; 2013 Jun; 54():59-67. PubMed ID: 23454197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.